Fundraising FoxBiotech Startups
11,136 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Trice Medical develops minimally invasive medical devices, including ultrasonic tenotomy systems for percutaneous tissue removal (treating tendinopathy, calcific tendonitis, and bone spurs), endoscopic carpal tunnel and ligament release systems, diabetic foot ulcer procedure tools, and portable high-resolution arthroscopy. The products are intended for use by clinicians performing minimally invasive orthopedic and wound-care procedures.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Trio Pharmaceuticals develops dual-targeting antibody drugs to treat cancer, using its TIE-ADC and TRAILBody platforms to kill cancer cells and overcome tumor immunosuppression while reducing treatment-related toxicity. Its pipeline targets blood cancers (AML/MDS), ovarian and endometrial cancers, and triple-negative breast and non-small cell lung cancers.
0 investors
0 investors
0 investors
0 investors
0 investors
Trovagene is a clinical-stage biotechnology company developing onvansertib, an oral PLK1 inhibitor, for treatment of cancers including RAS-mutated metastatic colorectal cancer, pancreatic cancer, small cell lung cancer, triple-negative breast cancer, and chronic myelomonocytic leukemia, with the goal of combining it with standard chemotherapy agents to improve patient outcomes.
0 investors
0 investors
0 investors
0 investors
0 investors
Túhura Biosciences is a clinical-stage biopharmaceutical company developing immuno-oncology therapies, including innate immune agonists and bi-specific immune-modulating antibody drug conjugates (ADCs). Its pipeline includes IMMUNE FX (IFX) and TBS-2025, with a Phase 3 registration trial underway.
0 investors
0 investors
Turn Medical develops and manufactures the Pronova-O2 Automated Prone Therapy System, a medical device for repositioning critically ill patients to improve patient outcomes and caregiver safety. The company serves clinicians, hospitals, and clinical institutions.
0 investors
Turn Therapeutics develops topical therapies for skin diseases using its proprietary PermaFusion drug delivery platform. The company's lead program, GX-03, is designed to treat moderate to severe eczema by reducing IL-36 signaling and downstream inflammatory cytokines.
0 investors